Resources All Resources|Real World Data Resources|Market Access Resources|Expanded Access Resources|Open Label Extensions Resources|Post-Approval Patient Programs Resources|Harnessing Real-World Data for Market Access Success24th July 2024/DOWNLOAD PDFStep-by-step EAP Management Process16th July 2024/DOWNLOAD PDFNavigating Asset Transitions that include [...]
Post-Approval Named Patient Programs A Post-Approval Named Patient Program (PA-NPP) allow Sponsors to make their approved medicines available in countries where they are not yet approved or commercially available. Sponsors can make their product available [...]
EAP VERSUS OLE Both an Open Label Extension (OLE) and an Expanded Access Program (EAP) can be used to provide continued treatment access after phase 3 clinical trials have ended.To help companies understand both programs [...]
SPONSOR CONSIDERATIONS FOR EAPs If your company is developing a drug that fulfils an unmet clinical need, you may have already started receiving patient enquiries about expanded access.We have put together this downloadable resource that [...]
Market Access Strategic Consulting We specialize in access strategies for rare, oncology, gene and cell therapies across Europe, supporting clients navigating the transition from clinical development to commercialization. Integrated Market Access Strategy A successful Market [...]
WEP Blog All PostsNursingExpanded Access ProgramsReal World DataEarly Access Programs – What to Consider as a Patient10th October 2023/Read MoreBenefits of Homecare Nursing in Clinical Trials19th September 2023/Read MoreWhere Can an EAP Fit Into the [...]
EXPANDED ACCESS POLICY TEMPLATES If your company is developing a drug that fulfils an unmet clinical need, you may need an Expanded Access Policy on your website.We have provided three templates, one for each of [...]
Emergency Drug Supply Service WEP Clinical has the infrastructure to provide next day delivery of emergency medicines to hospitals throughout the EEA and Australia. We recognize the urgency behind requests [...]
Leadership Team Executive Leadership JASWINDER KHERA Chief Executive Officer At WEP Clinical, Jaswinder oversees the growth and strategy of the business in the Americas. Jaswinder brings over 30 years of experience in the pharmaceutical Industry [...]
Testimonials What people are saying“They are experts in EAPs/Compassionate Use and as a Sponsor, we are impressed with the services provided. Beyond being knowledgeable, detail-oriented, accountable, and effective communicators, WEP Clinical [...]